Clinical trials
Phase 1 Neutropenia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 4 |
| 2015 | 6 |
| 2016 | 3 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 26 |
| Recruiting | 2 |
| Terminated | 2 |
| Unknown status | 2 |
| Withdrawn | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 3 |
| Pfizer | 3 |
| Enzon Pharmaceuticals, Inc. | 2 |
| Enzychem Lifesciences Corporation | 2 |
| National Heart, Lung, and Blood Institute (NHLBI) | 2 |
| Tianjin SinoBiotech Ltd. | 2 |
| University of Washington | 2 |
| Aileron Therapeutics, Inc. | 1 |
| BioGeneric Pharma | 1 |
| Children's Oncology Group | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neutropenia | 35 |
| Breast Neoplasms | 7 |
| Neoplasms | 6 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 5 |
| Burkitt Lymphoma | 4 |
| Leukemia, Myeloid, Acute | 4 |
| Lymphoma, Large B-Cell, Diffuse | 4 |
| Fever | 3 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 |
| Leukopenia | 3 |
Trials
Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.